Skin tests, including patch tests (PTs), prick tests, and intradermal tests (IDTs), are useful in
identifying the culprits of cutaneous adverse drug reactions (CADRs), and determining safer …

Drug hypersensitivity reactions (DHRs) to intravenous drugs can be severe and might leave
patients and doctors in a difficult position where an essential treatment or intervention has to …

A recent survey of the European Academy of Allergy and Clinical Immunology (EAACI) Drug
Allergy Interest Group (DAIG) on how European allergy specialists deal with beta‐lactam …

Drug hypersensitivity reactions (DHR s) are common, and the skin is by far the most
frequently involved organ with a broad spectrum of reaction types. The diagnosis of …

In drug hypersensitivity, drug provocation testing (DPT), also called drug challenge, is the
gold standard for investigation. In recent years, risk stratification has become an important …

All beta-lactam use is associated with a certain rate of adverse reactions. Many of these
adverse reactions result in an allergy to the beta-lactam being entered into the patient's …

In the manuscript, a strong recommendation is indicated by the phrase “we recommend” and
a conditional or weakened recommendation is indicated by “we suggest”. An open …

This guideline on diagnostic procedures for suspected beta-lactam antibiotic (BLA)
hypersensitivity was written by the German and Austrian professional associations for …

Most immune-mediated adverse drug reactions (IM-ADRs) involve the skin, and many have
additional systemic features. Severe cutaneous adverse drug reactions (SCARs) are an …

The specialties of allergy and clinical immunology have entered the era of precision
medicine with the stratification of diseases into distinct disease subsets, specific diagnoses …